SHANTHA FRANKS: Open Payments
NPI 1235275488 · PARAMUS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,039 in 17 payments from 7 companies in 2025. Trend: 2023 $357 · 2024 $195 · 2025 $1,039
Food & beverage: $1,039
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $290 |
| Lilly USA, LLC | 3 | $254 |
| Medtronic, Inc. | 3 | $189 |
| Boston Scientific Corporation | 1 | $140 |
| COLOPLAST CORP | 1 | $88 |
| Amgen Inc. | 2 | $58 |
| GlaxoSmithKline, LLC. | 1 | $20 |
Products named: Ozempic, SYMPLICITY G3, WATCHMAN FLX, MOUNJARO, ZEPBOUND, Titan, Wegovy, TRELEGY ELLIPTA.
Industry payments across NJ — which companies pay providers there.
